NCT03235245 2025-08-01
EBIN
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT02785952 2025-05-21
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
SWOG Cancer Research Network
Phase 3 Active not recruiting
NCT03443856 2024-01-05
VESTIGE
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Active not recruiting